Therapeutic live vaccines as a potential anticancer strategy

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Cancer treatment faces challenges in developing effective and safe therapies.
• Therapeutic cancer vaccines offer a promising approach by stimulating immune responses against cancer cells.
• Efficient antigen delivery systems are crucial for effective cancer vaccine development.

Purpose of the Study:

• To review current research on genetically modified bacteria and viruses as cancer therapy vectors.
• To explore the potential of live parasite-based vectors as a novel anticancer therapeutic approach.

Main Methods:

• Review of existing literature on bacterial and viral vectors for cancer vaccines.
• Discussion of the mechanisms of action for different live vaccine vectors.
• Exploration of emerging parasite-based vectors for gene delivery and heterologous gene expression.

Main Results:

• Bacterial strains like Salmonella and Listeria effectively colonize tumors and act as antitumor agents.
• Viral vectors utilize cellular machinery for protein expression, inducing T-cell responses.
• Nonpathogenic parasites are emerging as novel candidates for gene delivery and expression.

Conclusions:

• Live bacterial and viral vectors are valuable tools for cancer vaccine development, inducing systemic T-cell responses.
• There is a need for safer live vaccine vectors that enhance antigen presentation and immune responses.
• Live parasite-based vectors represent a novel and potentially safer approach for future cancer therapeutics.